{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T16:20:44Z","timestamp":1759335644789},"reference-count":15,"publisher":"Springer Science and Business Media LLC","issue":"10","license":[{"start":{"date-parts":[[2019,5,1]],"date-time":"2019-05-01T00:00:00Z","timestamp":1556668800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Clin Rheumatol"],"published-print":{"date-parts":[[2019,10]]},"DOI":"10.1007\/s10067-019-04572-8","type":"journal-article","created":{"date-parts":[[2019,5,1]],"date-time":"2019-05-01T08:02:28Z","timestamp":1556697748000},"page":"2941-2948","update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Can hyperuricemia predict glycogen storage disease (McArdle\u2019s disease) in rheumatology practice? (Myogenic hyperuricemia)"],"prefix":"10.1007","volume":"38","author":[{"given":"D\u00f6nd\u00fc","family":"\u00dcsk\u00fcdar Cansu","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bahattin","family":"Erdo\u011fan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cengiz","family":"Korkmaz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2019,5,1]]},"reference":[{"key":"4572_CR1","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1016\/j.maturitas.2018.10.012","volume":"118","author":"PC Robinson","year":"2018","unstructured":"Robinson PC (2018) Gout - an update of aetiology, genetics, co-morbidities and management. Maturitas. 118:67\u201373","journal-title":"Maturitas."},{"key":"4572_CR2","doi-asserted-by":"publisher","first-page":"822","DOI":"10.1002\/mus.880150711","volume":"15","author":"JG Puig","year":"1992","unstructured":"Puig JG, de Miguel E, Mateos FA, Miranda E, Romera NM, Espinosa A, Gij\u00f3n J (1992) McArdle's disease and gout. Muscle Nerve 15:822\u2013828","journal-title":"Muscle Nerve"},{"key":"4572_CR3","doi-asserted-by":"publisher","first-page":"728","DOI":"10.1212\/WNL.37.4.728-b","volume":"37","author":"O Hardiman","year":"1987","unstructured":"Hardiman O, Farrell M, McElvaney G, Tipton K, Staunton H (1987) Hyperuricemia in type V glycogenosis. Neurology. 37:728\u2013729","journal-title":"Neurology."},{"key":"4572_CR4","doi-asserted-by":"publisher","first-page":"321","DOI":"10.1172\/JCI109132","volume":"62","author":"HL Green","year":"1978","unstructured":"Green HL, Wilson FA, Hefferan P, Terrs' AB, Moran JR, Slonim AE, Claus TH, Burr IM (1978) ATP depletion, a possible role in the pathogenesis of hyperuricemia in glycogen storage disease type I. J Clin Invest 62:321\u2013328","journal-title":"J Clin Invest"},{"key":"4572_CR5","doi-asserted-by":"publisher","first-page":"204","DOI":"10.1159\/000116937","volume":"33","author":"K Jinnai","year":"1993","unstructured":"Jinnai K, Kono N, Yamamoto Y, Kanda F, Ohno S, Tsutsumi M, Yamada Y, Kawachi M, Tarui S, Fujita T (1993) Glycogenosis type V (McArdle's disease) with hyperuricemia. A case report and clinical investigation. Eur Neurol 33:204\u2013207","journal-title":"Eur Neurol"},{"key":"4572_CR6","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1056\/NEJM198707093170203","volume":"317","author":"I Mineo","year":"1987","unstructured":"Mineo I, Kono N, Hara N, Shimizu T, Yamada Y, Kawachi M, Kiyokawa H, Wang YL, Tarui S (1987) Myogenic hyperuricemia. A common pathophysiologic feature of glycogenosis types III, V, and VII. N Engl J Med 317:75\u201380","journal-title":"N Engl J Med"},{"key":"4572_CR7","doi-asserted-by":"publisher","first-page":"538","DOI":"10.1590\/0004-282X20140062","volume":"72","author":"RS Scalco","year":"2014","unstructured":"Scalco RS, Chatfield S, Godfrey R, Pattni J, Ellerton C, Beggs A, Brady S, Wakelin A, Holton JL, Quinlivan R (2014) From exercise intolerance to functional improvement: the second wind phenomenon in the identification of McArdle disease. Arq Neuropsiquiatr 72:538\u2013541","journal-title":"Arq Neuropsiquiatr"},{"key":"4572_CR8","doi-asserted-by":"publisher","first-page":"381","DOI":"10.1007\/978-1-4684-5673-8_62","volume":"253A","author":"N Hara","year":"1989","unstructured":"Hara N, Mineo I, Kono N, Kiyokawa H, Kawachi M, Yamada Y et al (1989) Myogenic hyperuricemia: a comparative study between type V and type VII glycogenosis. Adv Exp Med Biol 253A:381\u2013386","journal-title":"Adv Exp Med Biol"},{"key":"4572_CR9","doi-asserted-by":"publisher","first-page":"502","DOI":"10.1016\/0002-9343(61)90075-4","volume":"30","author":"CM Pearson","year":"1961","unstructured":"Pearson CM, Rimer DG, Mommaerts WF (1961) A metabolic myopathy due to absence of muscle phosphorylase. Am J Med 30:502\u2013517","journal-title":"Am J Med"},{"key":"4572_CR10","first-page":"241","volume-title":"Klippel JH (ed) primer on the rheumatic diseases, 13th edn.","author":"HK Cho\u0131","year":"2008","unstructured":"Cho\u0131 HK (2008) Clinical features. Epidemiology, pathology and pathogenesis. In: Klippel JH (ed) primer on the rheumatic diseases, 13th edn. Springer, New York, pp 241\u2013257"},{"key":"4572_CR11","doi-asserted-by":"publisher","first-page":"183","DOI":"10.3109\/01913123.2011.601404","volume":"35","author":"J Hicks","year":"2011","unstructured":"Hicks J, Wartchow E, Mierau G (2011) Glycogen storage diseases: a brief review and update on clinical features, genetic abnormalities, pathologic features, and treatment. Ultrastruct Pathol 35:183\u2013196","journal-title":"Ultrastruct Pathol"},{"key":"4572_CR12","doi-asserted-by":"publisher","first-page":"2851","DOI":"10.1007\/s10067-016-3290-1","volume":"35","author":"B Zhang","year":"2016","unstructured":"Zhang B, Zeng X (2016) Tophaceous gout in a female premenopausal patient with an unexpected diagnosis of glycogen storage disease type Ia: a case report and literature review. Clin Rheumatol 35:2851\u20132856","journal-title":"Clin Rheumatol"},{"key":"4572_CR13","doi-asserted-by":"publisher","first-page":"729","DOI":"10.1212\/WNL.37.4.729","volume":"37","author":"N Kono","year":"1987","unstructured":"Kono N, Mineo I, Tarui S (1987) Reply from the authors: hyperuricemia in type V glycogenosis. Neurology. 37:729","journal-title":"Neurology."},{"issue":"6","key":"4572_CR14","first-page":"1829","volume":"22","author":"Mark A. Tarnopolsky","year":"2016","unstructured":"Tarnopolsky MA (2016) Metabolic myopathies. Continuum (Minneap Minn). 22(6, muscle and neuromuscular junction disorders):1829\u20131851","journal-title":"CONTINUUM: Lifelong Learning in Neurology"},{"key":"4572_CR15","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1007\/s100670170105","volume":"20","author":"G Horneff","year":"2001","unstructured":"Horneff G, Paetzke I, Neuen-Jacob E (2001) Glycogenosis type V (McArdle's disease) mimicking atypical myositis. Clin Rheumatol 20:57\u201360","journal-title":"Clin Rheumatol"}],"container-title":["Clinical Rheumatology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10067-019-04572-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s10067-019-04572-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10067-019-04572-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,4,29]],"date-time":"2020-04-29T23:22:18Z","timestamp":1588202538000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s10067-019-04572-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,5,1]]},"references-count":15,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2019,10]]}},"alternative-id":["4572"],"URL":"https:\/\/doi.org\/10.1007\/s10067-019-04572-8","relation":{},"ISSN":["0770-3198","1434-9949"],"issn-type":[{"value":"0770-3198","type":"print"},{"value":"1434-9949","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,5,1]]},"assertion":[{"value":"25 March 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 April 2019","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 April 2019","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 May 2019","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"None.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Disclosures"}},{"value":"All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and\/or national research committee and with the 1964 Declaration of Helsinki and its later amendments or comparable ethical standards.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"Informed consent was obtained from our patient included in the study.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent"}}]}}